Application of esmketamine combined with high pressure airway surface anesthesia device in airway foreign body surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100043813

Enrollment

Unknown

Registered

2021-03-04

Start date

2021-03-05

Completion date

Unknown

Last updated

2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway foreign body

Interventions

Group E:Ketamine, sevoflurane

Group E:PROPOFOL, Remifentanil, sevoflurane

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with Airway Foreign Body; 2. ASA GRADE I-II; 3. BMI is in the range of less than 25kg/m2.

Exclusion criteria

Exclusion criteria: 1. Patients with severe congenital heart disease; 2. Patients with severe respiratory diseases; 3. Patients with acute laryngitis; 4. Patients with recent history of upper respiratory tract infection; 5. Patients allergic to this product and excipients; 6. Patients considered unsuitable by researchers.

Design outcomes

Primary

Measure	Time frame
Oxygenation;Suction frequency;Tidal volume;Terminal Carbon Dioxide partial pressure;Blood pressure;Heart rate;	—

Countries

China

Contacts

Public ContactXiaoshi Liu

Fushun Mining Bureau General Hospital of Liaoning Health Industry Group

15668563248@163.com+86 15668563248

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026